AGE/DOSE calc
user-icon
Brain & Neurons

Is Apigenin Safe? And How it Improves Sleep and Aging

While human studies are needed to determine its true effect on aging, apigenin may improve sleep in anxious individuals.

By Griffin Dean

Key Points: 

  • Apigenin is a naturally occurring molecule found most abundantly in chamomile. 
  • Clinical studies show that chamomile extract alleviates anxiety and depression, and improves the sleep of some populations. 
  • Animal studies demonstrate that apigenin raises NAD+ levels, which is known to have many anti-aging effects. 

In our fast-paced world, getting a good night’s sleep can be hard. A new survey showed that about 40 million (12%) Americans suffer from insomnia. Those with insomnia have difficulty falling or staying asleep and/or regularly wake up earlier than desired. This lack of adequate rest leads to daytime fatigue, depression, and anxiety. Moreover, insomnia is associated with increased rates of dementia, suggesting that years of disturbed sleep could invoke rapid brain aging. 

While various factors influence sleep quality, certain natural compounds may help promote better sleep. The same compounds may even delay the rate of aging by improving cellular health. One such compound is apigenin, a naturally occurring flavonoid found in many fruits and vegetables. This article explores how apigenin contributes to improved sleep and targets the underlying drivers of biological aging. 

What is Apigenin?

Apigenin is a bioactive flavonoid predominantly found in plants such as chamomile, parsley, celery, and some other fruits and vegetables. It is well-known for its anti-inflammatory, antioxidant, and anti-carcinogenic properties. However, its potential benefits in improving sleep quality are gaining attention due to its calming effects on the nervous system. Furthermore, its impact on cellular aging has placed it among one of the most promising anti-aging supplements. 

Evidence for Apigenin’s Sleep-Enhancing Effects 

Apigenin affects multiple biological processes thought to support healthy sleep. For example, apigenin has been shown to reduce oxidative stress in flies with induced dementia. Additionally, in rodents, apigenin reduces stress hormone levels and increases the neurotransmitter serotonin, which promotes sleep in humans. However, while apigenin is linked to such sleep biomarkers, very little research has explored how apigenin causally regulates sleep. 

Furthermore, clinical studies directly assessing apigenin’s effects are limited. However, a few clinical trials have tested the effect of chamomile extract, which contains about 1% apigenin. In patients with insomnia, 540 mg of chamomile extract trended toward improving daytime function, but this was not significant. Additionally, drinking chamomile tea was shown to alleviate postpartum depression and sleep quality problems in women. 

Perhaps more promising is the effect of chamomile extract on anxiety and depression. In individuals with generalized anxiety disorder, 1500 mg of chamomile extract reduced anxiety symptoms and 220-1100 mg helped to alleviate depression. While sleep was not directly measured in these studies, mood is known to affect sleep quality, and reducing anxiety and depression may improve sleep. 

Apigenin’s Anti-Aging Effects

Poor sleep is linked to accelerated aging and an increased risk of premature death. In turn, aging is linked to poor sleep quality. Hence, improving one or the other may benefit both. The anti-aging properties of apigenin have been demonstrated by extending the lifespan of various animal models. Furthermore, apigenin increases NAD+ (nicotinamide adenine dinucleotide) levels, which decline with age and may contribute to multiple age-related diseases, including heart and neurodegenerative disease. However, human studies are necessary to determine lifespan-extending effects.

One reason NAD+ declines with age is that it is consumed by various enzymes that repair our cells. As we age, our cells accumulate damage, and these enzymes (e.g., sirtuins) repair the damage. However, one NAD+-consuming enzyme called CD38 does not contribute to repairing cells and may be the primary reason for NAD+’s decline with age. If this is the case, then blocking the activity of CD38 could alleviate some aspects of rapid cellular aging. 

(Camacho-Pereira et al., 2016) NAD+ Declines While CD38 Activity Increases With Time. NAD+ levels (blue) decline while CD38 activity (red) increases with age in mice. NAD+ decline runs parallel to mitochondrial dysfunction, a universal driver of aging.

Among other functions, apigenin has been shown to inhibit CD38, preventing CD38 from devouring NAD+ for fuel. In this way, apigenin boosts NAD+ levels, similar to what NAD+ precursors like NR (nicotinamide riboside) and nicotinamide mononucleotide (NMN) do. Nevertheless, clinical studies are needed to determine how apigenin affects humans with respect to aging.  

Supplementing with Apigenin 

Apigenin may offer an effective way to improve sleep quality by reducing anxiety. It may also counteract the biological ravages of aging by boosting NAD+ levels. However, diet and exercise can also reduce anxiety and depression, improve sleep quality, and boost NAD+ levels. Thus, focusing on eating well and exercising consistently is recommended. 

With that being said, “apigenin is considered safe, even at high doses, and no toxicity has been reported. Nonetheless, at high doses, it can trigger muscle relaxation and sedation,” according to scientists. Considering that the most common recommended dosage for apigenin supplements — 50 mg — is relatively high compared to what is found in chamomile extract, a sedative effect should be expected. 

Ultimately, long-term clinical trials testing the effect of apigenin at various dosages, including 50 mg, on sleep and aging will help verify the safety of this supplement. It is possible that a lower or higher dose may be needed depending on one’s physical condition and desired outcome.  

References

Camacho-Pereira, J., Tarragó, M. G., Chini, C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., & Chini, E. N. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through a SIRT3-dependent mechanism. Cell Metabolism, 23(6), 1127. https://doi.org/10.1016/j.cmet.2016.05.006

Chang, M., & Chen, H. (2016). Effects of an intervention with drinking chamomile tea on sleep quality and depression in sleep disturbed postnatal women: A randomized controlled trial. Journal of Advanced Nursing, 72(2), 306-315. https://doi.org/10.1111/jan.12836

Kramer, D. J., & Johnson, A. A. (2024). Apigenin: A natural molecule at the intersection of sleep and aging. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1359176

Kusters, C. D. J., Klopack, E. T., Crimmins, E. M., Seeman, T. E., Cole, S., & Carroll, J. E. (2024). Short Sleep and Insomnia Are Associated With Accelerated Epigenetic Age. Psychosomatic medicine, 86(5), 453–462. https://doi.org/10.1097/PSY.0000000000001243

Madunić, J., Madunić, I. V., Gajski, G., Popić, J., & Garaj-Vrhovac, V. (2018). Apigenin: A dietary flavonoid with diverse anticancer properties. Cancer Letters, 413, 11-22. https://doi.org/10.1016/j.canlet.2017.10.041

Mao, J. J., Xie, S. X., Keefe, J. R., Soeller, I., Li, Q. S., & Amsterdam, J. D. (2016). Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine, 23(14), 1735-1742. https://doi.org/10.1016/j.phymed.2016.10.012

Mookerjee, N., Schmalbach, N., Antinori, G., Thampi, S., Windle-Puente, D., Gilligan, A., Huy, H., Andrews, M., Sun, A., Gandhi, R., Benedict, W., Chang, A., Sanders, B., Nguyen, J., Keesara, M. R., Patel, A., Hughes, I., Millstein, I., Hunter, K., . . . Roy, S. (2023). Comorbidities and Risk Factors Associated With Insomnia in the Elderly Population. Journal of Primary Care & Community Health, 14. https://doi.org/10.1177/21501319231168721

Salehi, B., Venditti, A., Sharifi-Rad, M., Kręgiel, D., Sharifi-Rad, J., Durazzo, A., Lucarini, M., Santini, A., Souto, E. B., Novellino, E., Antolak, H., Azzini, E., Setzer, W. N., & Martins, N. (2019). The Therapeutic Potential of Apigenin. International journal of molecular sciences, 20(6), 1305. https://doi.org/10.3390/ijms20061305

Sharma, P., Sharma, S., & Singh, D. (2020). Apigenin reverses behavioural impairments and cognitive decline in kindled mice via CREB-BDNF upregulation in the hippocampus. Nutritional neuroscience, 23(2), 118–127. https://doi.org/10.1080/1028415X.2018.1478653

Siddique, Y. H., Ara, G., Afzal, M., Varshney, H., Gaur, K., Subhan, I., Mantasha, I., & Shahid, M. (2022). Beneficial effects of apigenin on the transgenic Drosophila model of Alzheimer’s disease. Chemico-Biological Interactions, 366, 110120. https://doi.org/10.1016/j.cbi.2022.110120

Svensson, T., Saito, E., Svensson, A. K., Melander, O., Orho-Melander, M., Mimura, M., Rahman, S., Sawada, N., Koh, W. P., Shu, X. O., Tsuji, I., Kanemura, S., Park, S. K., Nagata, C., Tsugane, S., Cai, H., Yuan, J. M., Matsuyama, S., Sugawara, Y., Wada, K., … Inoue, M. (2021). Association of Sleep Duration With All- and Major-Cause Mortality Among Adults in Japan, China, Singapore, and Korea. JAMA network open, 4(9), e2122837. https://doi.org/10.1001/jamanetworkopen.2021.22837

Triantafillou, S., Saeb, S., Lattie, E. G., Mohr, D. C., & Kording, K. P. (2019). Relationship Between Sleep Quality and Mood: Ecological Momentary Assessment Study. JMIR mental health, 6(3), e12613. https://doi.org/10.2196/12613

Weng, L., Guo, X., Li, Y., Yang, X., & Han, Y. (2016). Apigenin reverses depression-like behavior induced by chronic corticosterone treatment in mice. European Journal of Pharmacology, 774, 50-54. https://doi.org/10.1016/j.ejphar.2016.01.015

Zick, S. M., Wright, B. D., Sen, A., & Arnedt, J. T. (2011). Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC complementary and alternative medicine, 11, 78. https://doi.org/10.1186/1472-6882-11-78

comment Comments
To The Top